Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury

Nephron - Clinical Practice

Volumn 123, Issue 1-2, 2013, Pages 67-73

  Susantitaphong, Paweena ^a,d   Perianayagam, Mary C ^a   Tighiouart, Hocine ^b   Liangos, Orfeas ^c   Bonventre, Joseph V ^e   Jaber, Bertrand L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e KLINIKUM COBURG   (Germany)

Author keywords

Acute kidney injury; KIM 1; NAG; Polymorphism; TNFA gene; GST

Indexed keywords

ACETYLGLUCOSAMINIDASE; CREATININE; CYSTATIN C; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE P1; KIDNEY INJURY MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; N ACETYL BETA GLUCOSAMINIDASE;

ACUTE KIDNEY FAILURE; ADULT; ALLELE; ARTICLE; ASSESSMENT OF HUMANS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE SCORE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN URINE LEVEL; RACE; SEPSIS; AGED; BLOOD LEVEL; CONTROLLED STUDY; GENE FREQUENCY; GROUPS BY AGE; MULTIPLE ORGAN FAILURE; RACE DIFFERENCE; SCORING SYSTEM; SEX DIFFERENCE; URINALYSIS; URINE LEVEL;

ACUTE KIDNEY INJURY; AGED; BOSTON; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879157350     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000351684     Document Type: Article

References (40)

1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16: 3365-3370.
2. Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL: Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006; 1: 43-51.
3. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
4. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W: Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30: 2051-2058.
5. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009; 302: 1179-1185.
6. Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB, Pereira BJ: Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004; 25: 212-219.
7. Liangos O, Balakrishnan VS, Pereira BJ, Jaber BL: Cytokine single nucleotide polymorphism. Role in acute renal failure. Contrib Nephrol. Basel, Karger, 2004, vol 144, pp 63-75.
8. Haase-Fielitz A, Haase M, Bellomo R, Dragun D: Genetic polymorphisms in sepsis-and cardiopulmonary bypass-associated acute kidney injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 75-91.
9. Perianayagam MC, Liangos O, Kolyada AY, Wald R, MacKinnon RW, Li L, Rao M, Balakrishnan VS, Bonventre JV, Pereira BJ, et al: NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 255-263.
10. Kolyada AY, Tighiouart H, Perianayagam MC, Liangos O, Madias NE, Jaber BL: A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury. Kidney Int 2009; 75: 1322-1329.
11. Alam A, O'Connor DT, Perianayagam MC, Kolyada AY, Chen Y, Rao F, Mahata M, Mahata S, Liangos O, Jaber BL: Phenylethanolamine Nmethyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nephron Clin Pract 2010; 114:c253-c259.
12. Perianayagam MC, Tighiouart H, Nievergelt CM, O'Connor DT, Liangos O, Jaber BL: CYBA gene polymorphisms and adverse outcomes in acute kidney injury: a prospective cohort study. Nephron Extra 2011; 1: 112-123.
13. Perianayagam MC, Tighiouart H, Liangos O, Kouznetsov D, Wald R, Rao F, O'Connor DT, Jaber BL: Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes. Kidney Int 2012; 82: 909-912.
14. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210.
15. Kinsey GR, Li L, Okusa MD: Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109:e102-e107.
16. Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009; 2009: 137072.
17. Lee DW, Faubel S, Edelstein CL: Cytokines in acute kidney injury (AKI). Clin Nephrol 2011; 76: 165-173.
18. White LE, Hassoun HT: Inflammatory mechanisms of organ crosstalk during ischemic acute kidney injury. Int J Nephrol 2012; 2012: 505197.
19. Kadiroglu AK, Sit D, Atay AE, Kayabasi H, Altintas A, Yilmaz ME: The evaluation of effects of demographic features, biochemical parameters, and cytokines on clinical outcomes in patients with acute renal failure. Ren Fail 2007; 29: 503-508.
20. Jaber BL, Liangos O, Pereira BJ, Balakrishnan VS: Polymorphism of immunomodulatory cytokine genes: implications in acute renal failure. Blood Purif 2004; 22: 101-111.
21. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riche F, et al: Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282: 561-568.
22. Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, Lui WY, Chiu JH, Lee TY: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000; 28: 2733-2736.
23. Yende S, Quasney MW, Tolley E, Zhang Q, Wunderink RG: Association of tumor necrosis factor gene polymorphisms and prolonged mechanical ventilation after coronary artery bypass surgery. Crit Care Med 2003; 31: 133-140.
24. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74: 243-248.
25. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
27. Knaus WA, Wagner DP: Multiple systems organ failure: epidemiology and prognosis. Crit Care Clin 1989; 5: 221-232.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
29. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV: ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999; 7: 127-128.
30. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
31. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, et al: Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 904-912.
32. Tobin J: Estimation for relationships with limited dependent variables. Econometrica 1958; 26: 24-36.
33. Jaber BL, Pereira BJ, Bonventre JV, Balakrishnan VS: Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. Kidney Int 2005; 67: 14-33.
34. Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafe M, Marchegiani F, Cardelli M, Galeazzi R, Giovagnetti S, Perna GP, et al: Tumor necrosis factor-alpha gene-308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis 2005; 16: 489-493.
35. Bishehsari F, Sharma A, Stello K, Toth C, O'Connell MR, Evans AC, Larusch J, Muddana V, Papachristou GI, Whitcomb DC: TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome (MODS) in acute pancreatitis. Pancreatology 2012; 12: 113-118.
36. Waterer GW, Quasney MW, Cantor RM, Wunderink RG: Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001; 163: 1599-1604.
37. Manchanda PK, Kumar A, Kaul A, Mittal RD: Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and endstage renal disease: a pilot study from north India. Clin Chim Acta 2006; 370: 152-157.
38. Nikolova PN, Ivanova MI, Mihailova SM, Myhailova AP, Baltadjieva DN, Simeonov PL, Paskalev EK, Naumova EJ: Cytokine gene polymorphism in kidney transplantation-impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome. Transpl Immunol 2008; 18: 344-348.
39. Teuffel O, Ethier MC, Beyene J, Sung L: Association between tumor necrosis factor-alpha promoter-308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis. Crit Care Med 2010; 38: 276-282.
40. Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, Huang C, King AJ, Pereira BJ: Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 2004; 65: 1449-1460.